The Link Between Unpredictable Chronic Mild Stress Model for Depression and Vascular Inflammation?
- 571 Downloads
Inflammation has been suggested to be associated with stress-induced depression and cardiovascular dysfunction. Tumor necrosis factor alpha (TNF-α) is a major cytokine in the activation of neuroendocrine, immune, and behavioral responses. In this study, we investigated the effects of infliximab (a TNF-α inhibitor) on endothelium-dependent vascular reactivity, systemic blood pressure, and endothelial nitric oxide synthase (eNOS) immunoreactivity in the unpredictable chronic mild stress (UCMS) model of depression in rats. There was no significant change between all groups in the systemic blood pressure. In UCMS, endothelium-dependent relaxation of the smooth muscle in response to carbachol was significantly decreased with 50 % maximal response (E max) and pD2 values compared with the controls. Infliximab was able to reverse this UCMS effect. Relaxation in response to the nitric oxide (NO) donor sodium nitroprusside and papaverine and KCl-induced contractile responses was similar between groups. In UCMS, decreased expression of eNOS was detected. Moreover, there was no significant change in UCMS + infliximab group with respect to control rats. Our results suggest that tumor necrosis factor-alpha (TNF-α) could be a major mediator of vascular dysfunction associated with UCMS, leading to decreased expression of eNOS.
KEY WORDSinfliximab TNF-α inflammation chronic stress vascular reactivity nitric oxide (NO)
This study was supported by a Grant from the Kocaeli University Research Fund and chosen for oral presentation at 22nd National Congress of Pharmacology on 4–7 November 2013 in Antalya, Turkey.
- 16.Yazir, Y., T. Utkan, and F. Aricioglu. 2012. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress. Basic & Clinical Pharmacology & Toxicology 111(3): 154–160.Google Scholar
- 17.Bayramgurler, D., A. Karson, Y. Yazir, I.K. Celikyurt, S. Kurnaz, and T. Utkan. 2013. The effect of etanercept on aortic nitric oxide-dependent vasorelaxation in an unpredictable chronic mild stress model of depression in rats. European Journal of Pharmacology 710(1–3): 67–72.PubMedCrossRefGoogle Scholar
- 21.Le Mellédo, J.M., N. Mahil, and G.B. Baker. 2004. Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry & Neuroscience 29: 414–416.Google Scholar
- 24.Isingrini, E., A. Surget, C. Belzung, J.L. Freslon, J. Frisbee, J. O’Donnell, V. Camus, and A. d’Audiffret. 2011. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiology & Behavior 103: 540–546.CrossRefGoogle Scholar
- 26.Nieuwdorp, M., M.C. Meuwese, H.L. Mooij, M.H. van Lieshout, A. Hayden, M. Levi, J.C. Meijers, C. Ince, J.J. Kastelein, H. Vink, and E.S. Stroes. 2009. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202(1): 296–303.PubMedCrossRefGoogle Scholar
- 34.Hürlimann, D., A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler, M. Béchir, L.E. Spieker, M. Neidhart, B.A. Michel, R.E. Gay, T.F. Lüscher, S. Gay, and F. Ruschitzka. 2002. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106: 2184–2187.PubMedCrossRefGoogle Scholar
- 37.Murphy, H.S., J.A. Shayman, G.O. Till, M. Mahrougui, C.B. Owens, U.S. Ryan, and P.A. Ward. 1992. Superoxide responses of endothelial cells to C5a and TNF-α: divergent signal transduction pathways. The American Journal of Physiology 263: 51–59.Google Scholar